An ancestral tRNA maturation enzyme repurposed for cytoplasmic non-coding RNA processing
This study reveals that the human cytoplasmic enzyme ELAC1 (RNase ZS), previously known for repairing damaged tRNAs, has been repurposed to process structured non-coding RNAs, specifically cleaving vault RNAs (vtRNAs) and Y RNAs, thereby demonstrating functional specialization between the ELAC1 and ELAC2 paralogs.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside every living cell, a vast library of instructions is constantly being read, copied, and edited. While the famous genetic code written in DNA gets most of the attention, a significant portion of the cell's work is carried out by a different kind of molecule: RNA. Some of these RNA molecules act as messengers, carrying instructions to build proteins, but many others are structural or regulatory tools that never become proteins at all. Among these non-coding RNAs are tiny, highly structured molecules produced by a specific cellular machine called RNA polymerase III. These molecules often have a distinct shape, featuring a stable, folded stem that ends in a loose, single-stranded tail. For decades, scientists knew that cells must trim and process these tails to make the molecules functional, but the specific tools responsible for this task in the cell's main compartment, the cytoplasm, remained a mystery.
The cell relies on a family of molecular scissors known as ribonuclease Z to cut the tails off precursor molecules. In humans, there are two versions of this enzyme: a long, highly efficient version that works in the nucleus and mitochondria, and a shorter, ancestral version that lives in the cytoplasm. The long version is essential for life, meticulously cutting the tails off transfer RNAs, which are the molecules that deliver amino acids to build proteins. The short version, however, has been a bit of an enigma. It is not required for the cell to survive, and while it can cut transfer RNAs, it does so with much less precision and speed than its long counterpart. This raised a simple but critical question: if this short enzyme is not the primary tool for making transfer RNAs, what is it actually doing in the cytoplasm?
A team of researchers set out to solve this puzzle by investigating the short enzyme, known as ELAC1, in human cells. They began by looking at what the enzyme was physically touching. Using a technique that freezes proteins and their attached RNA together, they mapped the molecules ELAC1 binds to inside the cell. The results were striking. While the enzyme did interact with some transfer RNAs, it showed a strong preference for a different group of structured non-coding RNAs, particularly a family called vault RNAs and another group called Y RNAs. These molecules share a specific architectural feature with the precursors of transfer RNAs: a folded stem followed by a loose tail. The researchers suspected that ELAC1 might be the specialized tool that trims these specific tails, a job that the more famous long enzyme does not perform.
To test this idea, the scientists isolated the ELAC1 enzyme and mixed it with purified vault RNA molecules in a test tube. The experiment provided a clear answer. When ELAC1 encountered the vault RNAs, it immediately and precisely cut off the loose tail at a specific spot, right where the single-stranded extension began. The researchers then compared this to the long enzyme, ELAC2, which is the primary cutter for transfer RNAs. Under the same conditions, the long enzyme barely touched the vault RNAs. This demonstrated a clear division of labor: the long enzyme is a specialist for transfer RNAs, while the short enzyme has evolved to handle a different set of structured molecules. The researchers also discovered that for ELAC1 to make this cut, the RNA molecule needed to maintain a specific overall shape; if the researchers altered the distant parts of the molecule's structure, the enzyme could no longer find its target.
The team then moved from the test tube back to living cells to see what happened when ELAC1 was removed. They used gene-editing tools to create human cells that could not produce the enzyme. Without ELAC1, the cells did not die, but they grew more slowly and showed changes in how they moved and attached to surfaces. More importantly, the cellular landscape of RNA changed dramatically. The cells accumulated vault RNAs and Y RNAs that still had their untrimmed tails attached. Furthermore, the population of tiny RNA fragments derived from these molecules shifted. In normal cells, the trimming by ELAC1 creates a specific set of small fragments that the cell uses for regulation. In the cells lacking the enzyme, these specific fragments disappeared, replaced by a different set of fragments that retained the unprocessed tails. This confirmed that ELAC1 is the gatekeeper that determines the final shape and size of these regulatory molecules.
The study also clarified what the enzyme does not do. For years, it was hypothesized that this short enzyme might be responsible for creating a specific type of small RNA fragment called a tRF-1, which is generated from the tail of transfer RNAs. However, when the researchers removed ELAC1, the levels of these specific fragments remained unchanged. This ruled out the idea that ELAC1 is the main producer of these fragments, reinforcing the view that the long enzyme handles the bulk of transfer RNA processing. Instead, the short enzyme appears to have a broader, more flexible role, recognizing a variety of structured RNAs that share a common architectural feature, rather than focusing on a single type of molecule.
These findings reshape our understanding of how the cell manages its RNA inventory. The short enzyme, once thought to be a backup or a less efficient version of the main cutter, is actually a specialized processor for a distinct class of non-coding RNAs. By precisely trimming the tails of vault RNAs and Y RNAs, ELAC1 ensures that these molecules are the correct size and shape to function in the cytoplasm. This work highlights how evolution can repurpose an ancient molecular tool, shifting its focus from the essential task of making proteins to the more nuanced regulation of the cell's structural and signaling RNAs. The cell does not rely on a single pair of scissors for all its cutting needs; instead, it employs a specialized team, where each member has evolved to handle a specific type of molecular job, ensuring that the complex machinery of life runs smoothly.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.